SELLAS Life Sciences Group, Inc. (SLS)

4.15 +0.11 (+2.72%) USD  |  NASDAQ  |  Feb 20, 16:00
4.25 +0.10 (+2.41%) After-Hours: 20:00
More

SELLAS Life Sciences Group Price Target Std Dev

Price Target Std Dev Chart

View Price Target Std Dev for SLS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Price Target Std Dev Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Price Target Std Dev Range, Past 5 Years

View Price Target Std Dev Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price Target Std Dev Benchmarks

View Price Target Std Dev Benchmarks
Start Trial
GT Biopharma, Inc. Upgrade
Amicus Therapeutics, Inc. Upgrade
Geron Corp. Upgrade
Vanda Pharmaceuticals, Inc. Upgrade
ADMA Biologics, Inc. Upgrade